AI Prescription Refills: Utah Program Raises Safety Concerns for Iowa Lawmakers

By John Damon | Just The News Iowa

A new program in Utah allowing patients to renew prescriptions through an AI chatbot is sparking a national debate over patient safety and the future of healthcare regulation. The initiative, which lets residents skip a doctor visit and use an online platform to refill eligible medications, has drawn sharp criticism from physicians who warn that artificial intelligence is not ready to replace licensed medical professionals.

As Iowa lawmakers consider similar legislation, the program raises urgent questions about how states should regulate AI-powered medical services and what safeguards are needed to protect patients.

What the Utah AI Prescription Program Does

Utah residents can now use Doctronic's AI-powered platform to renew eligible prescriptions online. After verifying a user's identity, the chatbot reviews their prescription history, confirms the prescription's validity through a national pharmacy database, and sends approved refills to a local pharmacy. Cases that require additional review are escalated to a licensed doctor through Doctronic's telehealth service.

The company plans to expand AI's role in healthcare by automating routine tasks such as ordering diagnostic tests and analyzing results. Doctronic's list of approximately 190 refillable medications includes blood thinners and other drugs that require careful monitoring due to the risk of serious side effects, including internal bleeding.

Doctors Warn of Serious Risks

Physicians have raised alarm about the program's safety. They note that blood thinners and similar medications require frequent dosage adjustments based on changes in a patient's condition. Doctors question whether an AI chatbot can make such clinical judgments safely.

The American Medical Association has voiced similar concerns, arguing that prescription renewals are not routine administrative tasks that can be reduced to a simple checklist. In response to safety concerns, several medications have already been removed from the list of drugs eligible for AI-assisted refills, including a medication used to treat irregular heart rhythms.

“Prescription renewals are not routine administrative tasks that can simply be reduced to a checklist,” the American Medical Association said in a statement.

Iowa Lawmakers Consider AI Healthcare Legislation

Iowa is among several states, including Idaho and others, that are considering legislation to formally regulate and license AI-powered medical services. Texas and Wyoming have already passed similar AI-friendly healthcare policies.

For Iowa lawmakers, the Utah program provides a cautionary example. The state's conservative leadership has traditionally supported limited government and free markets, but patient safety remains a top priority. The debate in Des Moines will likely focus on whether existing state laws, which limit prescription authority to licensed healthcare professionals, should be updated to include AI chatbots.

FDA Has Not Approved AI Chatbots for Clinical Use

An FDA spokesperson confirmed that the agency has not approved any AI-powered medical chatbots for clinical use. However, the regulator reiterated its support for responsible development of emerging healthcare technologies while keeping patient safety at the center of every decision.

“The FDA is committed to encouraging medical innovation and helping bring promising new technologies to patients, while keeping safety at the center of every decision,” the agency said in a statement.

What This Means for Iowa Patients

For now, Doctronic and several other AI healthcare companies are expected to continue expanding across states with varying regulatory approaches. Daniel Aaron of the University of Utah's law school warns that companies may benefit in the short term by expanding their business models, but risk compromising public trust and fueling backlash in the long term.

Iowa patients should stay informed about proposed legislation and contact their state representatives to voice concerns. The Iowa Board of Medicine and the Iowa Department of Public Health are expected to weigh in as the legislative process moves forward.

Frequently Asked Questions

Is the Utah AI prescription program safe?

Doctors and the American Medical Association have raised significant safety concerns, particularly regarding medications like blood thinners that require careful monitoring. Several drugs have already been removed from the program due to safety issues.

Will Iowa adopt a similar program?

Iowa lawmakers are considering legislation to regulate AI-powered medical services, but no final decisions have been made. The Utah experience is likely to inform the debate.

What medications are eligible for AI refills?

Doctronic's list includes approximately 190 medications, but blood thinners and drugs for irregular heart rhythms have been removed due to safety concerns.

How can I voice my opinion on this issue?

Iowa residents can contact their state representatives and senators, or submit comments to the Iowa Board of Medicine during the public comment period for any proposed legislation.